文献速递区域麻醉与超声疼痛医学

全身静脉利多卡因与超声引导收肌管阻滞在全膝关节置换术中的非劣效性随机双盲研究

Efficacy of systemic lidocaine versus ultrasound-guided adductor canal block for patients undergoing total knee arthroplasty: a randomized, double-blinded, non-inferiority study.
PubMed 文献 · Reg Anesth Pain Med · 2026-07-28

该随机双盲非劣效性试验纳入120例门诊全膝关节置换术患者,1:1随机接受单次收肌管阻滞加生理盐水输注或静脉利多卡因输注加假阻滞。主要结局术后24小时阿片类药物消耗量中位数差值5.0 mg(95%CI -11.2至16.2),低于预设非劣效界值30 mg口服吗啡当量。结论为持续静脉利多卡因在术后24小时镇痛方面非劣效于收肌管阻滞。

要点

  • 静脉利多卡因在TKA术后24小时阿片消耗量上非劣效于收肌管阻滞。
  • 收肌管阻滞在PACU期间阿片消耗和出院时疼痛评分更优。
  • 两组首次镇痛请求时间、恢复质量和满意度相似,无研究相关不良事件。

核心结论

  • 持续静脉利多卡因在全膝关节置换术后24小时镇痛方面非劣效于超声引导收肌管阻滞。
  • 收肌管阻滞提供更好的PACU即刻镇痛,但此后两种策略效果相当。
  • 静脉利多卡因可作为区域麻醉不可行时的有用选择。

研究设计与样本

  • 随机、双盲、非劣效性试验,纳入120例接受全膝关节置换术的患者。
  • 患者1:1随机接受单次收肌管阻滞加生理盐水输注或静脉利多卡因输注加假阻滞。
  • 主要结局为术后24小时阿片类药物消耗量,预设非劣效界值为30 mg口服吗啡当量(OME)。

主要发现

  • 利多卡因输注组24小时OME消耗中位数为57.5 mg(IQR 37.5-77.5),收肌管阻滞组为52.5 mg(IQR 30-77.5),中位差值5.0 mg(95%CI -11.2至16.2),低于非劣效界值。
  • PACU中收肌管阻滞组阿片消耗中位数比利多卡因组低10 mg OME(95%CI 1.0至11.2;p=0.02)。
  • PACU出院时收肌管阻滞组疼痛评分比利多卡因组低2分(95%CI 0.33至4;p=0.02)。
  • 两组首次镇痛请求时间、恢复质量和患者满意度相似,无研究相关不良事件。

关键数值与推荐

  • 非劣效界值为30 mg口服吗啡当量(OME)。
  • 主要结局24小时OME消耗中位差值5.0 mg(95%CI -11.2至16.2),低于非劣效界值。
  • PACU阿片消耗中位差值10 mg OME(95%CI 1.0至11.2;p=0.02),收肌管阻滞组更低。
  • PACU出院时疼痛评分中位差值2分(95%CI 0.33至4;p=0.02),收肌管阻滞组更低。

临床怎么用

  • 区域麻醉不可行时,可考虑持续静脉利多卡因作为全膝关节置换术后镇痛的替代方案。
  • 若需优化PACU即刻镇痛,收肌管阻滞可能更优,但24小时总体镇痛效果与静脉利多卡因相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total knee arthroplasty (TKA) is associated with significant postoperative pain; therefore, adductor canal block is commonly used as part of multimodal analgesia. Intravenous lidocaine may provide a practical alternative when regional anesthesia is not feasible. This study compared intravenous lidocaine with ultrasound-guided adductor canal block for postoperative opioid consumption, pain scores, and quality of recovery within the first 24 hours after outpatient TKA. METHODS: In this non-inferiority trial, 120 patients undergoing TKA were randomized 1:1 to receive either a single injection adductor canal block with saline infusion or intravenous lidocaine infusion with sham block. The primary outcome was opioid consumption 24 hours after surgery, with a prespecified non-inferiority margin of 30 mg oral morphine equivalents (OME). Secondary outcomes included pain scores, time to first analgesic request, quality of recovery, and patient satisfaction. RESULTS: Median OME consumption was 57.5 mg (IQR 37.5-77.5) in the lidocaine infusion group and 52.5 mg (IQR 30-77.5) in the adductor canal block group, with a median difference of 5.0 mg (95% CI -11.2 to 16.2), below the prespecified non-inferiority margin. In post-anesthesia care unit (PACU), median opioid consumption and pain scores at discharge were lower in the adductor canal block group than in the lidocaine group, with a median difference of 10 mg OME (95% CI 1.0 to 11.2; p=0.02) and two points (95% CI 0.33 to 4; p=0.02), respectively. There were no study-related adverse events. Time to first analgesic request, quality of recovery, and patient satisfaction were similar between groups. CONCLUSIONS: Continuous intravenous lidocaine was non-inferior to adductor canal block for postoperative analgesia at 24 hours after TKA. Although adductor canal block provided better immediate PACU analgesia, both strategies were comparable thereafter, supporting lidocaine as a useful option when regional anesthesia is not feasible.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Ramanujam V, Murthy A, Davignon K, et al. Efficacy of systemic lidocaine versus ultrasound-guided adductor canal block for patients undergoing total knee arthroplasty: a randomized, double-blinded, non-inferiority study. Reg Anesth Pain Med. 2026. PMID: 42521407. doi:10.1136/rapm-2026-107976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。